Beem blue, red, and infrared light therapy for healthier-looking skin

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-arm, observational Signal Phase study has participants undergo two 20-minute light therapy sessions per week at Efforia in New York City. Each session is divided into blue, red, and infrared phases designed to target different aspects of skin health. Participants complete weekly skin self-assessments, the Dermatology Life Quality Index, a facial skin survey, and pre- and post-study photos to measure changes. The design uses participants as their own control to gather preliminary safety and efficacy data on skin appearance and patient-reported outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Can read and understand English.
* US resident.
* Willing and able to follow the requirements of the protocol.

Exclusion Criteria:

* Individuals with Epilepsy
* Individuals with Photosensitivity
* Individuals with eye conditions
* Pregnant individuals
* Individuals with skin sensitivity
* Individuals taking certain light-sensitive medications

Where it's running

• Efforia
  New York, New York, United States Recruiting

Study contacts

• Study coordinator: Matthew Amsden
• Email: help@efforia.com
• Phone: (646) 679-2479

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Skin Color and Sun Damage: Using AI to Classify Pigmentation and Phototype

  Researchers are testing AI-based photo analysis to accurately classify skin pigmentation, phototype, and sun damage in adults to improve skin health risk assessments and care.

  Recruiting at 5 sites Region Skane · Brisbane, Queensland and 12 other locations · NCT07765303

• Western Sweden Systemic Sclerosis Project

  This project will collect blood, skin and DNA samples from people with systemic sclerosis in Western Sweden to try to find genes, proteins, and immune changes linked to how the disease starts and gets worse.

  Recruiting Sahlgrenska University Hospital · Gothenburg, Sweden · NCT07345052

• Long-term effects of Ultherapy Prime using multiple depths versus a single 1.5 mm depth for the lower face and neck

  This trial will test whether Ultherapy Prime delivered at multiple depths works better than a single 1.5 mm depth to lift, tighten, and smooth the lower face and neck in adults aged 25–65 with moderate to severe skin laxity.

  Recruiting The Levine Center for Plastic Surgery · New York, New York · NCT07224308

• Cross-modal in vivo imaging of skin microstructure

  This project will use a handheld imaging device (VIO/FG-30350) to see if microscopic skin features correspond to visible skin appearance in people aged 2 to 90 with different skin health.

  Recruiting Enspectra Health · Mountain View, California · NCT07188948

• Hyaluronic acid plus recombinant collagen volumizing filler for facial wrinkles and sagging

  This trial will try a hyaluronic acid and recombinant collagen filler to reduce facial wrinkles, scars, and tissue laxity in non-smoking adults aged 18–70.

  Recruiting Taumedika s.r.l. · Roma · NCT06336044

• Mobile sun protection support to help young adults stay safe in the sun

  This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07830394

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.